ME00606B - A process for the preparation of n,n'-bis[2, 3-dihydroxypropyl] -5-[ (hydroxyacetyl) methylamino]-2, 4,6-triiodo-1, 3-benzenedi carboxamide - Google Patents
A process for the preparation of n,n'-bis[2, 3-dihydroxypropyl] -5-[ (hydroxyacetyl) methylamino]-2, 4,6-triiodo-1, 3-benzenedi carboxamideInfo
- Publication number
- ME00606B ME00606B MEP-2009-88A MEP200988A ME00606B ME 00606 B ME00606 B ME 00606B ME P200988 A MEP200988 A ME P200988A ME 00606 B ME00606 B ME 00606B
- Authority
- ME
- Montenegro
- Prior art keywords
- compound
- solution
- viii
- isoserinol
- process according
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 28
- 230000008569 process Effects 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title abstract description 21
- 125000000350 glycoloyl group Chemical group O=C([*])C([H])([H])O[H] 0.000 title abstract 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims description 67
- 239000000243 solution Substances 0.000 claims description 64
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- -1 5-hydroxy-1,3-benzenedicarboxylic acid n-butyl diester Chemical class 0.000 claims description 29
- KQIGMPWTAHJUMN-UHFFFAOYSA-N 3-aminopropane-1,2-diol Chemical compound NCC(O)CO KQIGMPWTAHJUMN-UHFFFAOYSA-N 0.000 claims description 27
- 239000007864 aqueous solution Substances 0.000 claims description 22
- 239000000047 product Substances 0.000 claims description 21
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 20
- QNVNLUSHGRBCLO-UHFFFAOYSA-N 5-hydroxybenzene-1,3-dicarboxylic acid Chemical compound OC(=O)C1=CC(O)=CC(C(O)=O)=C1 QNVNLUSHGRBCLO-UHFFFAOYSA-N 0.000 claims description 18
- 239000002244 precipitate Substances 0.000 claims description 15
- 230000015572 biosynthetic process Effects 0.000 claims description 14
- 230000002378 acidificating effect Effects 0.000 claims description 13
- 239000011347 resin Substances 0.000 claims description 13
- 229920005989 resin Polymers 0.000 claims description 13
- VUSMNMBGHJTLOV-UHFFFAOYSA-N 1-n,3-n-bis(2,3-dihydroxypropyl)-5-hydroxy-2,4,6-triiodobenzene-1,3-dicarboxamide Chemical compound OCC(O)CNC(=O)C1=C(I)C(O)=C(I)C(C(=O)NCC(O)CO)=C1I VUSMNMBGHJTLOV-UHFFFAOYSA-N 0.000 claims description 11
- 239000000725 suspension Substances 0.000 claims description 9
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 8
- HOZLOOPIXHWKCI-UHFFFAOYSA-N 2-chloro-n-methylacetamide Chemical compound CNC(=O)CCl HOZLOOPIXHWKCI-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 230000029936 alkylation Effects 0.000 claims description 8
- 238000005804 alkylation reaction Methods 0.000 claims description 8
- 159000000000 sodium salts Chemical class 0.000 claims description 8
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 7
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 238000007112 amidation reaction Methods 0.000 claims description 6
- 239000003729 cation exchange resin Substances 0.000 claims description 6
- 238000004090 dissolution Methods 0.000 claims description 6
- 238000005886 esterification reaction Methods 0.000 claims description 6
- 238000006192 iodination reaction Methods 0.000 claims description 6
- 239000011541 reaction mixture Substances 0.000 claims description 6
- UYHIIWRTQHSZBJ-UHFFFAOYSA-N 1-n,3-n-bis(2,3-dihydroxypropyl)-5-hydroxybenzene-1,3-dicarboxamide Chemical compound OCC(O)CNC(=O)C1=CC(O)=CC(C(=O)NCC(O)CO)=C1 UYHIIWRTQHSZBJ-UHFFFAOYSA-N 0.000 claims description 5
- 150000001768 cations Chemical class 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 230000026045 iodination Effects 0.000 claims description 5
- 239000004793 Polystyrene Substances 0.000 claims description 4
- 238000007351 Smiles rearrangement reaction Methods 0.000 claims description 4
- 239000002168 alkylating agent Substances 0.000 claims description 4
- 229940100198 alkylating agent Drugs 0.000 claims description 4
- 230000009435 amidation Effects 0.000 claims description 4
- 230000003197 catalytic effect Effects 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 4
- 230000008025 crystallization Effects 0.000 claims description 4
- 230000032050 esterification Effects 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 229920002223 polystyrene Polymers 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- RZINTRRZGJKOOY-UHFFFAOYSA-N 1-n,3-n-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[2-(methylamino)-2-oxoethoxy]benzene-1,3-dicarboxamide Chemical compound CNC(=O)COC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I RZINTRRZGJKOOY-UHFFFAOYSA-N 0.000 claims description 3
- COFWQRPEYJADHT-UHFFFAOYSA-N 1-n,3-n-bis(2,3-dihydroxypropyl)-5-[(3-hydroxy-2-oxopropyl)amino]-2,4,6-triiodobenzene-1,3-dicarboxamide Chemical compound OCC(O)CNC(=O)C1=C(I)C(NCC(=O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I COFWQRPEYJADHT-UHFFFAOYSA-N 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 3
- 238000007171 acid catalysis Methods 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 3
- SVAYRULJDHTRGP-UHFFFAOYSA-N NCC(O)CO.OC(=O)C(O)=O Chemical compound NCC(O)CO.OC(=O)C(O)=O SVAYRULJDHTRGP-UHFFFAOYSA-N 0.000 claims description 2
- 239000003957 anion exchange resin Substances 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 150000007529 inorganic bases Chemical class 0.000 claims description 2
- 238000005342 ion exchange Methods 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- 235000011149 sulphuric acid Nutrition 0.000 claims description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 2
- 230000002152 alkylating effect Effects 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 7
- NJKDOADNQSYQEV-UHFFFAOYSA-N iomeprol Chemical compound OCC(=O)N(C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NJKDOADNQSYQEV-UHFFFAOYSA-N 0.000 abstract description 5
- 229960000780 iomeprol Drugs 0.000 abstract description 5
- 239000002872 contrast media Substances 0.000 abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 8
- 239000000543 intermediate Substances 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 239000003456 ion exchange resin Substances 0.000 description 5
- 229920003303 ion-exchange polymer Polymers 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- VEUUMBGHMNQHGO-UHFFFAOYSA-N ethyl chloroacetate Chemical compound CCOC(=O)CCl VEUUMBGHMNQHGO-UHFFFAOYSA-N 0.000 description 4
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 238000001728 nano-filtration Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 229940075564 anhydrous dibasic sodium phosphate Drugs 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 238000010533 azeotropic distillation Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 229940023913 cation exchange resins Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- XQZXYNRDCRIARQ-LURJTMIESA-N iopamidol Chemical compound C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I XQZXYNRDCRIARQ-LURJTMIESA-N 0.000 description 1
- 229960004647 iopamidol Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Polyamides (AREA)
Abstract
Novi postupak pripremanja N,N’-bis [ 2,3-dihidroksipropil ] -5- [ (hidroksiacetil)metilamino ] -2,4,6-trijodo-1,3-benzendikarboksamidaformule (I) opšte poznatog kao Iomeprol, novog ne-jonskog kontrasnog agensakoji pokazuje vrlo dobru sigurnost i efektivnu kontrastnost.A New Process for the Preparation of N, N'-Bis [2,3-Dihydroxypropyl] -5- [(hydroxyacetyl) methylamino] -2,4,6-triodo-1,3-benzenedicarboxamideformula (I) commonly known as Iomeprol, a novel non- The ionic contrast agent exhibits very good security and effective contrast.
Description
Predmetni pronalazak odnosi se na nove postupke za pripremanje N,N’-bis[2,3-dihidroksipropil]-5-[(hidroksiacetil)metilamino]-2,4,6-trijodo-1,3-benzendikarboksamida iz formule (I), obično poznatog kao Iomeprol, novi ne-jonski kontrastni agens koji pokazuje odličnu sigurnost i efektivan kontrast. The present invention relates to new processes for the preparation of N,N'-bis[2,3-dihydroxypropyl]-5-[(hydroxyacetyl)methylamino]-2,4,6-triiodo-1,3-benzenedicarboxamide of formula (I) , commonly known as Iomeprol, a new non-ionic contrast agent that demonstrates excellent safety and effective contrast.
Sinteza jedinjenja iz formule (I) prvi put je opisana u EP 26,281, ali sledeći EP 365,541 sugerisao je drugačiji put sinteze, baziran na Smiles-ovoj reakciji rearanžiranja derivata 5-alkoksi-2,4,6-trijodo-1,3-benzendikarboksamida u bazičnim vodenim uslovima da se dobiju odgovarajući derivati 5-(hidroksiacil)amino, prema shemi 1 (vidi niže). The synthesis of compounds of formula (I) was first described in EP 26,281, but the following EP 365,541 suggested a different synthesis route, based on the Smiles rearrangement reaction of 5-Alkoxy-2,4,6-triiodo-1,3-benzenedicarboxamide derivatives under basic aqueous conditions to give the corresponding 5-(hydroxyacyl)amino derivatives, according to Scheme 1 (see below).
Prednosti ove druge sinteze nad onom opisanom u EP 26,281 uglavnom proističu iz izbegavanja nekih reagenasa i rastvarača kao što su: tionil hlorid, sirećetni anhidrid, metil jodid, metilen hlorid i hloroform, kao i reakcije (kao što je katalitička redukcija sa vodonikom), koje su u uslovima industrijske proizvodnje sredinski i toksikološki opasne pa prema tome zahtevaju posebne pogonske uslove. The advantages of this second synthesis over the one described in EP 26,281 mainly stem from the avoidance of some reagents and solvents such as: thionyl chloride, acetic anhydride, methyl iodide, methylene chloride and chloroform, as well as reactions (such as catalytic reduction with hydrogen), which are environmentally and toxicologically dangerous in the conditions of industrial production and therefore require special operating conditions.
Ključni intermedijer sintetičkog puta je jedinjenje iz formule (VII), koje se sintetiše kao što je opisano u EP 185,130 i izneseno u shemi 1. (videti stranu 2) The key intermediate of the synthetic pathway is the compound of formula (VII), which is synthesized as described in EP 185,130 and outlined in Scheme 1. (see page 2)
Postupak sadrži upotrebu 5-hidroksi-1,3-benzendikarboksilne kiseline kao startnog jedinjenja, koja se estrifikuje pod uobičajenim uslovima sa MeOH i kiselom katalizom do metil diestra iz formule (II). Ovaj poslednji je topao amidifikovan sa 1-amino-2,3-propandiolom (obično imenovanog kao izoserinol), sa 100% reagensa u višku. Metanol koji se formira tokom reakcije se destiluje i višak amina se uklanja pomoću jakih katijonskih smola da se dobije jedinjenje formule (III). Rezultirajući diamid se jodira u vodenom bazičnom rastvoru sa rastvorom 2.5M KICl2 da se dobije jedinjenje formule (IV). The process involves the use of 5-hydroxy-1,3-benzenedicarboxylic acid as the starting compound, which is esterified under usual conditions with MeOH and acid catalysis to the methyl diester of formula (II). The latter is hot amidified with 1-amino-2,3-propanediol (commonly named isoserinol), with 100% reagent in excess. The methanol formed during the reaction is distilled and the excess amine is removed using strong cationic resins to give the compound of formula (III). The resulting diamide is iodinated in an aqueous basic solution with a 2.5M KICl2 solution to give the compound of formula (IV).
Nisu dati detalji koji razmatraju uslove ponovnog dobijanja jedinjenja (IV) koje se transformiše u odgovarajuću natrijumovu so (V), pa zatim dok je vruće reaguje sa metil bromacetatom u dimetilacetamidu da bi dalo, nakon rekristalizacije iz metanola, jedinjenje formule (VI), koje je predmet amidizacije za vrućim metilaminom da produkuje jedinjenje (VII). EP 185,130 otkriva jedinjenje (VII) kao intermedijer za sintezu odre|enog broja kontrasnih agenasa izvedenih iz N,N'-bis(2,3-dihidroksipropil)-2,4,6-trijodo-5-hidroksi-1,3-benzendikarboksilni kiseli amid. No details are given considering the conditions for recovering compound (IV) which is transformed into the corresponding sodium salt (V) and then reacted while hot with methyl bromoacetate in dimethylacetamide to give, after recrystallization from methanol, the compound of formula (VI), which is subject to amidation with hot methylamine to produce compound (VII). EP 185,130 discloses compound (VII) as an intermediate for the synthesis of a number of contrast agents derived from N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-hydroxy-1,3-benzenedicarboxylic acid amide.
Me|utim, odmeravanje ovog postupka pokazuje neočekivane tehničke probleme, ukratko: However, weighing this procedure shows unexpected technical problems, in short:
- u formiranju dimetil estra formule (II), kao što je to dobro poznato u literaturi, zbog karakteristika metanola, potrebna je ne-katalitička količina H2SO4 da pomeri ravnotežu prema formiranju estra. Pod tim uslovima, monometil sulfat formira se kao sporedni produkt koji, analogno dobro poznatom dimetil sulfatu, je opasan po zdravlje; - in the formation of the dimethyl ester of formula (II), as is well known in the literature, due to the characteristics of methanol, a non-catalytic amount of H2SO4 is required to shift the equilibrium towards the formation of the ester. Under these conditions, monomethyl sulfate is formed as a side product which, analogous to the well-known dimethyl sulfate, is dangerous for health;
- jedinjenje (IV), kao i natrijumova so formule (V), mora se izolovati iz vodenog rastvora; - the compound (IV), as well as the sodium salt of the formula (V), must be isolated from the aqueous solution;
- alkilacija jedinjenja (V) sa metil bromacetatom mora se obaviti u dimetilacetamidu, koji se mora reciklirati iz ekonomskih razloga; - alkylation of compound (V) with methyl bromoacetate must be carried out in dimethylacetamide, which must be recycled for economic reasons;
- jedinjenje (VI) mora se prečistiti kristalizacijom iz metanola; - compound (VI) must be purified by crystallization from methanol;
- u opisanim uslovima jodiranja, jod se mora upotrebiti u višku, na štetu sledećeg sintetičkog koraka, na takav način da višak može delovati kao oksidant u odnosu na alkoholnu grupu prisutnu u amidima na 3- i 5– položajima da se dobije sledeće jedinjenje - in the described iodination conditions, iodine must be used in excess, to the detriment of the next synthetic step, in such a way that the excess can act as an oxidant in relation to the alcohol group present in the amides at the 3- and 5-positions to obtain the following compound
koje je teško razdvojivo od jedinjenja (IV) i koje, nakon uzastopnih sintetičkih koraka, produkuje nečistoću koja kontaminira konačni produkt, Iomeprol. Ta nečistoća je značajno toksična i njeno formiranje se prema tome mora sprečiti što je više moguće. which is difficult to separate from compound (IV) and which, after successive synthetic steps, produces an impurity that contaminates the final product, Iomeprol. This impurity is significantly toxic and its formation must therefore be prevented as much as possible.
Tražen je sigurni alternativni postupak za pripremanje (VII), sa ciljem da se se napravi industrijska sinteza sredinski mnogo sigurnija, izbegavajući upotrebu organskih rastvarača što je više moguće, dok se sprečava formiranje sporednih produkata opasnih po zdravlje. A safe alternative procedure for the preparation of (VII) was sought, with the aim of making the industrial synthesis much more environmentally safe, avoiding the use of organic solvents as much as possible, while preventing the formation of by-products hazardous to health.
Prema tome, objekt predmetnog pronalaska je novi postupak za pripremanje Iomeprola, sadržeći korake prikazane u sledećoj shemi 2: Therefore, the object of the present invention is a new process for the preparation of Iomeprol, comprising the steps shown in the following Scheme 2:
esterifikacija sa butanolom i kataliza kiselinom da se dobije 5-hidroksi-1,3-benzendikarboksilični kiseli butil diestar (VIII); esterification with butanol and acid catalysis to give 5-hydroxy-1,3-benzenedicarboxylic acid butyl diester (VIII);
a) amidizacija jedinjenja (VIII) sa izoserinolom u višku da se dobije vodeni rastvor N,N'-bis-(2,3-dihidroksipropil)-5-hidroksi-1,3-benzen-dikarboksamid (III); a) amidation of compound (VIII) with excess isoserinol to obtain an aqueous solution of N,N'-bis-(2,3-dihydroxypropyl)-5-hydroxy-1,3-benzene-dicarboxamide (III);
b) jodiranje jedinjenja (III) sa ICl, u stohiometrijskim količinama ili u višku od 1%, da se dobije N,N'-bis-(2,3-dihidroksipropil)-5-hidroksi-2,4,6-trijodo-1,3-benzendikarboksiamid (IV); b) iodination of compound (III) with ICl, in stoichiometric amounts or in an excess of 1%, to obtain N,N'-bis-(2,3-dihydroxypropyl)-5-hydroxy-2,4,6-triiodo- 1,3-benzenedicarboxamide (IV);
c) alkilacija jedinjenja (IV) sa jedinjenjem (IX), 2-hloro-N-metil-acetamidom u vodenom rastvoru da se dobije N,N'-bis(2,3-dihidroksipropil)-2,4,6-trijodo-5-[2-(metilamino)-2-oksoetoksi]-1,3-benzen-dikarboksamid (VII), koji se koristi kao vlažni produkt; konačno, c) alkylation of compound (IV) with compound (IX), 2-chloro-N-methyl-acetamide in aqueous solution to give N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo- 5-[2-(methylamino)-2-oxoethoxy]-1,3-benzene-dicarboxamide (VII), which is used as a wet product; finally,
d) Smiles-ov rearanžman jedinjenja (VII) u baznim uslovima i uzastopno prečićšavanje da se dobije Iomeprol (I). d) Smiles rearrangement of compound (VII) under basic conditions and successive reduction to give Iomeprole (I).
Dalji objekt predmetnog pronalaska je postupak pripremanja jedinjenja (VII), korisnog intermedijera za pripremu jodiranog agensa kontrasta kao što je opisano u EP 185,130, koje sadrži korake a), b), c) i d) i i na dalje konačno sušenje (VII). A further object of the present invention is a process for the preparation of compound (VII), a useful intermediate for the preparation of an iodinated contrast agent as described in EP 185,130, comprising steps a), b), c) and d) and further final drying (VII).
Suprotno onome što je obelodanjeno u EP 185,130, postupak predmetnog pronalaska karakteriše se time što svi sintetički koraci od b) do e), uključujući pripremanje alkilirajućeg agensa formule (IX), se obavljaju u vodenom rastvoru, i u tome da se organski rastvarači izbegavaju i u tome da ponovno dobijanje pojedinačnih intermedijera nije više neophodan, ali je moguće da se radi kontinuirano direktno u rastvorima samih intermedijera. Contrary to what is disclosed in EP 185,130, the process of the present invention is characterized in that all synthetic steps b) to e), including the preparation of the alkylating agent of formula (IX), are carried out in aqueous solution, and that organic solvents are avoided and that that the recovery of individual intermediates is no longer necessary, but it is possible to work continuously directly in solutions of the intermediates themselves.
U koraku a) formiranje butil diestra formule (VIII) omogućuje da se uspešno prevazi|u prethodno navedeni problemi. U stvari, ako se radi prema postupcima pronalaska, moguće je upotrebiti katalitičku količinu H2SO4, koja preferentno odgovara 6% po molu 5-hidroksi-1,3-benzendikarboksilične kiseline. In step a), the formation of the butyl diester of formula (VIII) enables the previously mentioned problems to be successfully overcome. In fact, if carried out according to the methods of the invention, it is possible to use a catalytic amount of H 2 SO 4 , which preferably corresponds to 6% per mole of 5-hydroxy-1,3-benzenedicarboxylic acid.
Alternativno, može se upotrebiti katalitička količina p-toluensulfoničnog kiselog monohidrata, poželjnije u količinama ekvivalentnim 6% po molu 5-hidroksi-1,3-benzendikarboksilične kiseline. Reakcija esterifikacije može se tako|e izvesti na toploti i pod postupno opadajućim pritiskom, umesto na atmosferskom pritisku. Alternatively, a catalytic amount of p-toluenesulfonic acid monohydrate may be used, preferably in amounts equivalent to 6% per mole of 5-hydroxy-1,3-benzenedicarboxylic acid. The esterification reaction can also be carried out at heat and under gradually decreasing pressure, instead of at atmospheric pressure.
Jedinjenje (VIII) može se povratiti bilo direktnom kristalizacijom iz konačne reakcione smeše, prethodano koncentrisane, ili putem percipitacije iz alkalnog vodenog rastvora, prethodnom eliminacijom organskog rastvarača. U prvom slučaju konačna kristalizacija se obavlja na hladnom (T od oko 5oC) i većina prinosa mora se povratiti kroz ponovljeno koncentrisanje matičnih tečnosti, ili se matične tečnosti prvog prinosa moraju reciklirati i upotrebiti u uzastopnim reakcijama esterifikacije. U drugom slučaju (ponovno dobijanje iz alkalnog vodenog rastvora) reakciona mešavina je koncentrisana u talog, koji je uzastopno tretiran sa vodenim rastvorom neorganske baze (preferentno natrijum ili kalijum hidroksida ili amonijaka): kontrolisanim hla|enjem nastale emulzije, jedinjenje (VIII) dobijeno je kao delimično čvrsti kristal. Jedinjenje (VIII) može se filtrirati ili centrifugirati ili filter-presovati i osušiti. Compound (VIII) can be recovered either by direct crystallization from the final reaction mixture, previously concentrated, or by precipitation from an alkaline aqueous solution, with prior elimination of the organic solvent. In the first case, the final crystallization is carried out cold (T of about 5oC) and most of the yield must be recovered through repeated concentration of the mother liquors, or the mother liquors of the first yield must be recycled and used in successive esterification reactions. In the second case (reproduction from an alkaline aqueous solution) the reaction mixture is concentrated into a precipitate, which is successively treated with an aqueous solution of an inorganic base (preferably sodium or potassium hydroxide or ammonia): by controlled cooling of the resulting emulsion, compound (VIII) is obtained as a partially solid crystal. Compound (VIII) can be filtered or centrifuged or filter-pressed and dried.
Alternativno, jedinjenje (VIII) može biti ponovno rastvoreno u n-butanolu i nastali rastvor može se upotrebiti u sledećem koraku b). Prednosti direktne upotrebe rastvora su: Alternatively, compound (VIII) can be redissolved in n-butanol and the resulting solution can be used in the next step b). The advantages of direct use of the solution are:
-mogućnost da se izbegne korak ponovnog dobijanja vlažnog produkta, - the possibility to avoid the step of recovering the wet product,
-da se izbegne korak sušenja, koji zahteva produženi tretman u statičkom sušaču pod vakumom na 30-40oC, - to avoid the drying step, which requires prolonged treatment in a static dryer under vacuum at 30-40oC,
-jedinjenje (II) je čvrsto sa niskom tačkom topljenja. -compound (II) is a solid with a low melting point.
Korak b) je gotovo u potpunosti ekvivalentan onom opisanom u gornjem patentu i sastoji se u amidizaciji jedinjenja (VIII) sa izoserinolom. Step b) is almost entirely equivalent to that described in the above patent and consists in the amidation of compound (VIII) with isoserinol.
Reakcija je izvo|ena u uslovima topljenja (tj. u 120% izoserinola u višku), na temperaturi od 90-95oC, tokom oko 12 časova, uz uklanjanje formiranog n-butanola putem destilacije pod vakumom. Kada se koristi rastvor butanola jedinjenja (VIII), rastvor se uklanja pre reakcije da se dobije jedinjenje (VIII) kao istopljni talog, koji se konačno dodaje sa izoserinolom. Na kraju reakcije masa se pokupi sa vodom da bi se dobio vodeni rastvor jedinjenja (III), u obliku fenola, koji je prečišćen iz viška izoserinola kroz katjonsku smolu za razmenu. Tečnosti se konačno koncentrišu i pH se podešava na 9-10 dodavanjem natrijum hidroksida dobijajući tako vodeni rastvor natrijumove soli koja odgovara jedinjenju (III). The reaction was carried out under melting conditions (ie in 120% isoserinol in excess), at a temperature of 90-95oC, for about 12 hours, with the removal of the formed n-butanol by distillation under vacuum. When a butanol solution of compound (VIII) is used, the solution is removed before the reaction to give compound (VIII) as a precipitate, which is finally added with isoserinol. At the end of the reaction, the mass is taken up with water to obtain an aqueous solution of compound (III), in the form of phenol, which is purified from excess isoserinol through a cation exchange resin. The liquids are finally concentrated and the pH is adjusted to 9-10 by adding sodium hydroxide to obtain an aqueous solution of the sodium salt corresponding to compound (III).
Višak izoserinola se ponovo dobija na prigodan način i reciklira postupkom rastvaranja iz smole sa razblaženim rastvorom amonijaka. Rastvor se koncentriše u talog i zatim prečišćava putem obrazovanja izoserinol oksalata u rastvoru etanola, kako je to opisano u Italijanskoj patentnoj prijavi MI 97 A 000782. So se filtrira i zatim rastvara u vodi. Rastvor se prečišćava kroz jako kiseli polistirenski matriks katjonske smole za razmenu i izoserinol se ponovo dobija rastvaranjem sa razblaženim rastvorom amonijaka. Rastvor koji sadrži ponovo dobijeni izoserinol koncentriše se do taloga. The excess isoserinol is recovered in a convenient way and recycled by the dissolution process from the resin with a dilute ammonia solution. The solution is concentrated to a precipitate and then purified by the formation of isoserinol oxalate in an ethanol solution, as described in Italian patent application MI 97 A 000782. The salt is filtered and then dissolved in water. The solution is purified through a strongly acidic polystyrene matrix of cation exchange resin and the isoserinol is recovered by dissolution with dilute ammonia solution. The solution containing the recovered isoserinol is concentrated to a precipitate.
Alternativno, korak b) može se izvesti bez ponovnog dobijanja butil diestra dobijenog u koraku a). U tom slučaju, na kraju reakcije amidacije jedinjenja (VIII) sa izoserinolom, nakon razblaživanja sa vodom, reakciona smeša je prečišćena iz viška izoserinola pomoću hromatografije na prvoj koloni koja je sadržala jako kiseli katjonski razmenjivač i iz anjonskih nečistoća putem hromatografije na drugoj koloni koja je sadržala slabo bazni anjonski razmenjivač, povezan u seriji sa prvom kolonom. Jako kisela katjonska izmenjivačka smola odabrana je od onih koje su bile komercijalno dostupne, kao što je Rohm & Hass Amberjetâ 1200H i slabi bazni anjonski izmenjivač kao na primer, Diaion Reliteâ MG1. Alternatively, step b) can be carried out without recovering the butyl diester obtained in step a). In this case, at the end of the amidation reaction of compound (VIII) with isoserinol, after dilution with water, the reaction mixture was purified from excess isoserinol by chromatography on a first column containing a strongly acidic cation exchanger and from anionic impurities by chromatography on a second column that contained a weakly basic anion exchanger, connected in series with the first column. A strongly acidic cation exchange resin was selected from those that were commercially available, such as Rohm & Hass Amberjetâ 1200H and a weak base anion exchanger such as Diaion Reliteâ MG1.
Jodiranje je obavljena pomoću ICl kao jodirajućeg agensa (44.5% I2 u rastvoru HCl) u vodenom neutralnom medijumu u vrlo uskom rasponu pH od 6 do 7, dodavanjem dvobaznog natrijum fosfata ili CaCO3 u višku, na sobnoj temperaturi. U stvari, bilo je zapaženo da na pH >7 Smiles-ovi rearanžmani, koji su karakteristični za korak e), se već odigravaju, i prema tome konačno jedinjenje (I) se delom formira. Me|utim, prigodno je da se koriste mogućnosti jedinjenja (VII) da kristalizuje iz vode na tom koraku da bi se uspešno uklonile sve nečistoće iz prethodnih sintetičkih koraka. Iodination was performed using ICl as an iodizing agent (44.5% I2 in HCl solution) in an aqueous neutral medium in a very narrow pH range of 6 to 7, by adding dibasic sodium phosphate or CaCO3 in excess, at room temperature. In fact, it was observed that at pH >7 Smiles rearrangements, which are characteristic of step e), already take place, and therefore the final compound (I) is partially formed. However, it is convenient to use the ability of compound (VII) to crystallize from water at that step in order to successfully remove all impurities from the previous synthetic steps.
Jedan od najvažnijih aspekata pronalaska je kontrola količine jodirajućeg agensa, koji se dobija inovaciono i posebo je jednostavan za upotrebu čak i u industrijskoj razeri, putem potenciometra. Pod tim uslovima višak oksidanta može se minimizirati (do oko 1%) izbegavajući tako neželjene sporedne reakcije oksidacije. One of the most important aspects of the invention is the control of the amount of iodizing agent, which is obtained in an innovative way and is particularly easy to use even in an industrial destroyer, by means of a potentiometer. Under these conditions, the excess of oxidant can be minimized (up to about 1%), thus avoiding unwanted oxidation side reactions.
Neophodno je da jodirajući agens gotovo u potpunosti bude ekvivalentan stohiometrijskoj količini ili malom višku (oko 1%), i višak se zatim uništava sa natrijum bisulfitom. Nastali rastvor se direktno podvrgava koraku alkilacije d), izbegavajući tako korak koristeći amido derivate dobijene u nukleofilnoj supstituciji na slobodnoj fenol grupi jedinjenja (IV), umesto derivata estra, kako je to obelodanjeno u EP 185,130. It is necessary that the iodizing agent be almost entirely equivalent to the stoichiometric amount or a slight excess (about 1%), and the excess is then destroyed with sodium bisulphite. The resulting solution is directly subjected to alkylation step d), thus avoiding the step using amido derivatives obtained by nucleophilic substitution on the free phenol group of compound (IV), instead of ester derivatives, as disclosed in EP 185,130.
Posebno, uzimajući u obzir tehnička upustva US 5,763,663, cela sinteza može biti kraća za jedan korak. Navedeni patent, u stvari, obelodanjuje direktnu reakciju prekursora fenola sa reaktivnim jedinjenjem, koje već sadrži željenu amido grupu. Navedeni patent svakako, samo opisuje upotrebu postupka pripremanja intermedijera za sintezu S-N,N'-bis[2-hidroksi-1-(hidroksimetil)etil]-5-[(2-hidroksi-1-oksopropil)amino]-2,4,6-trijodo-1,3-benzendikarboksamida, poznatog pod komercijalnim imenom Iopamidol. Pomenuti intermedijer je, naravno, nekorisan za pripremu Iomeprol-a, koji je objekat predmetnog pronalska. In particular, taking into account the technical instructions of US 5,763,663, the whole synthesis can be shortened by one step. The said patent, in fact, discloses the direct reaction of a phenol precursor with a reactive compound, which already contains the desired amido group. The mentioned patent, of course, only describes the use of a procedure for preparing intermediates for the synthesis of S-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy-1-oxopropyl)amino]-2,4, 6-triiodo-1,3-benzenedicarboxamide, known under the commercial name Iopamidol. The mentioned intermediate is, of course, useless for the preparation of Iomeprol, which is the object of the subject invention.
Alkilacija jedinjenja (IV) sa jedinjenjem (IX) odigrava se na pH od oko 6 na temperaturi od 95oC, dok se alkilirajući agens dodaje u količinama od 1.8-2.2 mola po molu supstrata. Na kraju reakcije, za koju je obično potrebno 7 sati, nastala suspenzija se ohladi i uključi u izolacioni korak jedinjenja (VII). Alkylation of compound (IV) with compound (IX) takes place at a pH of about 6 at a temperature of 95oC, while the alkylating agent is added in amounts of 1.8-2.2 moles per mole of substrate. At the end of the reaction, which usually takes 7 hours, the resulting suspension is cooled and included in the isolation step of compound (VII).
Alternativno, reakcija jodiranja može se obaviti bez pufera, održavajući pH na željenim vrednostima (izme|u 6 i 7) dodavanjem NaOH. Alternatively, the iodination reaction can be performed without buffer, maintaining the pH at the desired values (between 6 and 7) by adding NaOH.
U tom slučaju alkilacija jedinjenja (IV) sa jedinjenjem (IX) tako|e se obavlja održavanjem pH na oko 6 dodavanjem natrijum hidroksida, na temperaturi od 95oC. In this case, the alkylation of compound (IV) with compound (IX) is also carried out by maintaining the pH at about 6 by adding sodium hydroxide, at a temperature of 95oC.
Alkilirajući agens (IX) priprema se direktnom reakcijom etil hloracetata i metilamina (40% vodeni rastvor), koji je dodan etil hloracetatu održavajući temperaturu od –10oC do 0oC. Metilamin se dodaje u blagom višku (5-15%). Reakcija obično zahteva 30 minuta; na kraju mešavina se razblažuje sa vodom i pH se podešava do kiselih vrednosti (izme|u 2 i 5). Rezultirajući vodeni rastvor jedinjenja (IX) ima koncentraciju od oko 30% w/w i može se koristiti direktno u koraku alkilacije. Alkylating agent (IX) is prepared by direct reaction of ethyl chloroacetate and methylamine (40% aqueous solution), which is added to ethyl chloroacetate maintaining the temperature from –10oC to 0oC. Methylamine is added in a slight excess (5-15%). The reaction usually requires 30 minutes; at the end, the mixture is diluted with water and the pH is adjusted to acidic values (between 2 and 5). The resulting aqueous solution of compound (IX) has a concentration of about 30% w/w and can be used directly in the alkylation step.
Korak e) može se konvencionalno odigrati pod uslovima obelodanjenim u EP 365,541. Step e) can be conventionally performed under the conditions disclosed in EP 365,541.
Posebno je poželjno pečišćavanje konačnog rastvora prema proceduri opisanoj u WO 97/30788 pomoću posebnih naprava dizajniranih za regenerisanje izmešanih perli jonoizmenjivačkih smola, uključujući katjonske izmenjivačke smole i anjonske izmenjivačke smole. Alternativno, konačno prečišćavanje jedinjenja (I) može se izvesi prema proceduri opisanoj u WO 98/56504, primer 5. It is particularly preferred to purify the final solution according to the procedure described in WO 97/30788 using special devices designed to regenerate mixed beads of ion exchange resins, including cation exchange resins and anion exchange resins. Alternatively, the final purification of compound (I) can be carried out according to the procedure described in WO 98/56504, example 5.
[ta više, na kraju rearanžiranja, pH rastvora može se podesiti do 5.5 uklanjanjem prisutnog natrijum hidroksida pomoću slabo kiselih katjonskih smola, umesto dodavanja hidrohlorne kiseline. Pripremanje je izneseno u detaljima u eksperimentalnom delu. Moreover, at the end of the rearrangement, the pH of the solution can be adjusted to 5.5 by removing the sodium hydroxide present using weakly acidic cation resins, instead of adding hydrochloric acid. The preparation is detailed in the experimental section.
Sledeći primer ilustruje najbolje eksperimentalne uslove da se obavi postupak pronalaska. The following example illustrates the best experimental conditions to carry out the process of the invention.
Eksperimentalni deo Experimental deo
Primer 1 First 1
Pripremanje jedinjenja (VII) N,N'-bis(2,3-dihidroksipropil)-2,4,6-trijodo-5-[2-(metilamino)-2-oksoetoksi]-1,3-benzendikarboksamida Preparation of compound (VII) N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[2-(methylamino)-2-oxoethoxy]-1,3-benzenedicarboxamide
A. Pripremanje 5-hidroksi-1,3-benzendikarboksilnog kiselog butil diestra A. Preparation of 5-hydroxy-1,3-benzenedicarboxylic acid butyl diester
Esterifikacioni reaktor puni se pod azotom sa 101.7 kg n-butanola i 62 kg (320 mola) 5-hidroksi-1,3-benzendikarboksilne kiseline. 2 kg koncentrovane sumporne kiseline dodaje se uz mešanje. Nastala suspenzija se zagreva do ključanja rastvarača, uklanjajući vodu azeotropičnom destilacijom: oko 1.5 čas nakon početka zagrevanja dobija se čist rastvor, koji se zagreva dodatna 3 časa. Nakon kompletiranja reakcije rastvor se ohladi do oko 50oC i koncentriše pod vakumom da se dobije željeni produkt kao istopljeni talog. Držanjem temperature taloga iznad 70oC, 0.15M rastvor NaOH se ukapa unutra, da se dobije emulzija istopljenog konačnog jedinjenja dispergovanog u vodi, čiji je pH podešen na 8.5 sa 0.15M NaOH. Emulzija se ohladi do 43oC uz jako mešanje, zaseje sa 1 kg (3.3 mola) konačnog jedinjenja kristalizovanog iz vode i lagano ohladi do 28oC. Rezultujuća suspenzija se ohladi do 17oC i zatim filter-presuje, ispiranjem čvrstog dela sa vodom do neutralnog. The esterification reactor is charged under nitrogen with 101.7 kg of n-butanol and 62 kg (320 moles) of 5-hydroxy-1,3-benzenedicarboxylic acid. 2 kg of concentrated sulfuric acid is added with stirring. The resulting suspension is heated until the solvent boils, removing water by azeotropic distillation: about 1.5 hours after the start of heating, a clear solution is obtained, which is heated for an additional 3 hours. After completion of the reaction, the solution is cooled to about 50oC and concentrated under vacuum to obtain the desired product as a molten precipitate. Keeping the temperature of the precipitate above 70oC, a 0.15M NaOH solution is dropped in, to obtain an emulsion of the molten final compound dispersed in water, the pH of which is adjusted to 8.5 with 0.15M NaOH. The emulsion was cooled to 43°C with vigorous stirring, seeded with 1 kg (3.3 mol) of the final compound crystallized from water and cooled slowly to 28°C. The resulting suspension is cooled to 17oC and then filter-pressed, washing the solid part with water until neutral.
Vlažni produkt se direktno ponovo rastvori u filter-presi sa n-butanolom. Dobija se rastvor težine oko 280 kg, koji sadrži 96-97 kg (326-330 mola) željenog jedinjenja. The wet product is directly redissolved in a filter press with n-butanol. A solution weighing about 280 kg is obtained, containing 96-97 kg (326-330 moles) of the desired compound.
Prinos: 95-96% Yield: 95-96%
B. Pripremanje N,N'-bis-(2,3-dihidroksipropil)-5-hidroksi-1,3-benzendikarboksamida B. Preparation of N,N'-bis-(2,3-dihydroxypropyl)-5-hydroxy-1,3-benzenedicarboxamide
Kondenzacija izme|u 41.6 kg (141.3 mola) jedinjenja pripremljenog u koraku A) i 56.8 kg (623.4 mola) izoserinola se obavlja u reaktoru opremljenog sa mešalicom, na temperaturi od oko 90-95oC. Kada se reakcija kompletira konačni rastvor se razre|uje sa vodom i prećišćava kroz matriks jako kisele polistirenske jonoizmenjivačke smole, da se ukloni višak izoserinola, rastvaranjem sa vodom. Rastvor iz kolone se koncentriše do standardne zapremine, zatim alkinizuje sa rastvorom natrijum hidroksida, koji se dodaje da se dobije rastvor odgovarajuće natrijumove soli. Condensation between 41.6 kg (141.3 moles) of the compound prepared in step A) and 56.8 kg (623.4 moles) of isoserinol is carried out in a reactor equipped with a stirrer, at a temperature of about 90-95oC. When the reaction is complete, the final solution is diluted with water and purified through a matrix of strongly acidic polystyrene ion exchange resin, to remove excess isoserinol, by dissolving it with water. The solution from the column is concentrated to standard volume, then alkynized with sodium hydroxide solution, which is added to give a solution of the corresponding sodium salt.
Prema tome dobija se 227.5 kg 20% rastvora koji sadrži 45.4 kg (138.6 mola u obliku fenola) željenog jedinjenja. Accordingly, 227.5 kg of a 20% solution containing 45.4 kg (138.6 moles in the form of phenol) of the desired compound is obtained.
Prinos 97.9%. Yield 97.9%.
HPLC test: >98% (područje) HPLC test: >98% (range)
Izoserinol se lako ponovo dobija rastvaranjem iz smole sa razbalženim rastvorom amonijaka. Rastvor se koncentriše do taloga i zatim prečišćava. Izoserinol se salifikuje sa oksalnom kiselinom u rastvoru etanola. So se filtrira i zatim rastvara u vodi. Rastvor se prečišćava kroz jako kiseli matriks polistirenske jonoizmenjivačke katjonske smole i izoserinol je ponovo dobijen rastvaranjem sa razblaženim rastvorom amonijaka. Rastvor koji sadrži ponovo dobijeni izoserinol se koncentriše do taloga. Isoserinol is easily recovered by dissolving it from the resin with diluted ammonia solution. The solution is concentrated to a precipitate and then purified. Isoserinol is salified with oxalic acid in ethanol solution. The salt is filtered and then dissolved in water. The solution is purified through a strongly acidic matrix of polystyrene ion exchange cation resin and isoserinol is recovered by dissolution with dilute ammonia solution. The solution containing the recovered isoserinol is concentrated to a precipitate.
Prinos 76.3%. Yield 76.3%.
C. Pripremanje 2-hloro-N-metil-acetamida C. Preparation of 2-chloro-N-methyl-acetamide
Kondenzovanje 34.5 kg (283 mola) etil hlor acetata i 24 kg (310 mola) monometilamina (40% vodeni rastvor) se obavlja u reaktoru na temperaturi od –5oC. Nakon kompletiranja dodavanja rastvor se drži na stalnoj temperaturi dodatnih 30 minuta, zatim se razblaži sa 40.5 kg vode i pH je podešen do kiselih vrednosti (pH< 5), da se dobije 30% vodenog rastvora (99 kg) koji sadrži 29.7 kg (276.2 mola) 2-hloro-N-metilacetamida. Condensation of 34.5 kg (283 moles) of ethyl chloroacetate and 24 kg (310 moles) of monomethylamine (40% aqueous solution) is performed in a reactor at a temperature of -5oC. After the addition is complete, the solution is kept at a constant temperature for an additional 30 minutes, then it is diluted with 40.5 kg of water and the pH is adjusted to acidic values (pH< 5), to obtain a 30% aqueous solution (99 kg) containing 29.7 kg (276.2 moles) of 2-chloro-N-methylacetamide.
Prinos: 98% Yield: 98%
D. Priprema N-N'-bis(2,3-dihidroksipropil)-2,4,6-trijodo-5-[2-(metilamino)-2-oksoetoksi]-1,3-benzendarboksamida D. Preparation of N-N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[2-(methylamino)-2-oxoethoxy]-1,3-benzenedarboxamide
227.5 kg rastvora (koje odgovara 45.5 kg suvog produkta u obliku fenola; 138.6 mola) dobijeno u koraku B) razblaži se sa 50 kg vode i dodano sa 10 kg anhidrovanog dvobaznog natrijum fosfata. Istovremeno ICl (44.5% vodeni rastvor I2) i 30% rastvora natrijum hidroksida se dodaju, održavajući pH na 7. Dodavanje se završava kada se redoks potencijal stabilizuje na 500 mV. Ukupno se napuni 120 kg ICl i 107 kg natrijum hidroksida. 227.5 kg of solution (corresponding to 45.5 kg of dry product in the form of phenol; 138.6 moles) obtained in step B) is diluted with 50 kg of water and added with 10 kg of anhydrous dibasic sodium phosphate. Simultaneously ICl (44.5% aqueous solution of I2) and 30% sodium hydroxide solution are added, maintaining the pH at 7. The addition is completed when the redox potential stabilizes at 500 mV. In total, 120 kg of ICl and 107 kg of sodium hydroxide are charged.
Nakon toga 2.5 kg natrijum bisulfita se doda da se uništi višak jodina i da se potencijal smanji na 20 mV. After that 2.5 kg of sodium bisulphite is added to destroy the excess iodine and to reduce the potential to 20 mV.
Doda se 18.5 kg anhidrovanog dibaznog natrijum fosfata i 99 kg rastvora 2-hloro-N-metil-acetamida (276.2 mola) pripremljenog u koraku C), pH se podesi do 6.2 dodavanjem 3 kg HCl. Mešavina se zagreva na 95oC i meša 7 časova, zatim se ohladi do 60oC i razblaži sa 50 kg vode. Konačna suspenzija se ponovo filterpresuje, uz ispiranje čvrstog dela sa vodom. 18.5 kg of anhydrous dibasic sodium phosphate and 99 kg of the 2-chloro-N-methyl-acetamide solution (276.2 mol) prepared in step C are added, the pH is adjusted to 6.2 by adding 3 kg of HCl. The mixture is heated to 95oC and stirred for 7 hours, then cooled to 60oC and diluted with 50 kg of water. The final suspension is again filter-pressed, with the solid part being washed with water.
Prema tome dobija se 130 kg željenog vlažnog produkta ekvivalentnog 90 kg suvog produkta (115.8 mola). Accordingly, 130 kg of the desired wet product equivalent to 90 kg of dry product (115.8 moles) is obtained.
Prinos: 83.6% Yield: 83.6%
E. Priprema jedinjenja (I) E. Preparation of compound (I)
90 kg jedinjenja pripremljenog u koraku D) se suspenduje u 400 L dejonizovane vode i refluksuje. Suspenzija se dodaje sa 310 g 30% (w/w) natrijum hidroksida, zatim zagreva do 120oC pod pritiskom, uz održavanje te temperature tokom jednog časa. Mešavina se ohladi do 50oC, doda sa 7.7 kg 30% (w/w) natrijum hidroksida i zatim postepeno ohladi do 40oC tokom 2 časa. Nakon dodatna 4 sata na 40oC mešavina se ohladi do 20oC i pH se podesi do 5.5 sa hlorovodoničnom kiselinom. Dobijeni rastvor se napuni u 160 L R&H Amberlite 1600 absorbujuću smolu, puneći tečnost u nanofiltrirajuću jedinicu opremljenu sa Desal DK4040 membranom. Nakon punjenja, izvrši se rastvaranje sa 800 L vode na 40oC, i ponovo sakupljanje rastvora u nanofiltrirajuću jedinicu tanka. Tokom rastvaranja ili na kraju nanofiltrirajuća jedinica radi sve dok se volumen rastvora koji se nalazio u jedinici nije redukovao na oko 200 L. Na taj način se postiže koncentrisanje kao i eliminisanje većine natrijum hlorida sadržanog u razblaženom rastvoru. 90 kg of the compound prepared in step D) is suspended in 400 L of deionized water and refluxed. The suspension is added with 310 g of 30% (w/w) sodium hydroxide, then heated to 120oC under pressure, maintaining that temperature for one hour. The mixture is cooled to 50oC, added with 7.7 kg of 30% (w/w) sodium hydroxide and then gradually cooled to 40oC over 2 hours. After an additional 4 hours at 40oC, the mixture is cooled to 20oC and the pH is adjusted to 5.5 with hydrochloric acid. The resulting solution was filled into 160 L of R&H Amberlite 1600 absorbent resin, filling the liquid into a nanofiltration unit equipped with a Desal DK4040 membrane. After filling, dissolve with 800 L of water at 40oC, and collect the solution again in the nanofiltration unit of the tank. During the dissolution or at the end, the nanofiltration unit works until the volume of the solution in the unit is reduced to about 200 L. In this way, the concentration and elimination of most of the sodium chloride contained in the diluted solution is achieved.
Nastali rastvor N,N'-bis(2,3-dihidroksipropil)-5-[(hidroksiacetil)metilamino]-2,4,6-trijodo-1,3-benzendikarboksamida, koji se dalje označavati kao rastvor A, sadrži 80 kg željenog produkta, oko 0.05 mola/L organskih jonskih nećistoća (karboksilnih aromatičnih kiselina) i 0.03 mola neorganskih soli (uglavnom NaCl). The resulting solution of N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)methylamino]-2,4,6-triiodo-1,3-benzenedicarboxamide, which will be referred to as solution A, contains 80 kg of the desired product, about 0.05 mol/L of organic ionic impurities (carboxylic aromatic acids) and 0.03 mol of inorganic salts (mainly NaCl).
200 kg 40% (w/w) rastvora A se puni sa stopom protoka od 40 L/h u jedinicu koja je opisana u primeru WO 97/30788, napunjenu sa istim količinama istih jonoizmenjivača, prethodno regenerisanih prema istom metodu kao u ovom primeru. 200 kg of 40% (w/w) solution A is charged at a flow rate of 40 L/h into the unit described in Example WO 97/30788, filled with the same amounts of the same ion exchangers, previously regenerated according to the same method as in this example.
Ure|aj za razblaživanje je opremljen sa analizatorom provodljivosti i sa fotometrom za merenje apsorpcije na 280 nm, da bi se detektovalo prisustvo organskog produkta u rastvoru. Rastvor se odbacuje sve dok apsorpcija rastvora ne počne da raste brzo, što ukazuje na prisustvo koncentrovanog organskog produkta. The dilution device is equipped with a conductivity analyzer and a photometer for measuring absorbance at 280 nm, in order to detect the presence of an organic product in the solution. The solution is discarded until the absorbance of the solution begins to rise rapidly, indicating the presence of a concentrated organic product.
Od tada, rastvor se sakuplja u tank sve do iscrpljivanja rastvora A. Tokom ponovnog dobijanja te frakcije, koja sadrži većinu organskog produkta, provodljivost ostaje ispod 0.1 mS/cm. From then on, the solution is collected in the tank until solution A is exhausted. During recovery of that fraction, which contains most of the organic product, the conductivity remains below 0.1 mS/cm.
Kada se rastvor A iscrpe, mešana osnova se ispere sa 30 L vode sa istim protokom i konačno ponovo sa 150 L vode sa stopom protoka od 100 L/h, uvek sakupljajući rastvor u isti produkcioni frakcioni tank. When solution A is exhausted, the mixed base is washed with 30 L of water at the same flow rate and finally again with 150 L of water at a flow rate of 100 L/h, always collecting the solution in the same production fractionation tank.
Tokom tog koraka provodljivost rastvora je tako|e vrlo mala, sem za neznatni pik provodljivosti, sa maksimumom na 20 mS/cm, na kraju pranja na niskom stepenu protoka, verovatno zahvaljujući osmotskim efektima odmah nakon pika produkta. During this step, the conductivity of the solution is also very low, except for a slight conductivity peak, with a maximum at 20 mS/cm, at the end of the low flow rate wash, probably due to osmotic effects immediately after the product peak.
Frakcija koja odgovara desalinizovanom produktu, koji je oslobo|en od jona hlora i karboksilnih kiselina, se termalno koncentriše u tanki talog koji sadrži 15% vode. Produkt se zatim vraća u gotovo potpuno čistom obliku dodavanjem apsolutnog etanola na refluks temperaturi, hla|enjem i filtracijom. The fraction corresponding to the desalinated product, which is freed from chlorine ions and carboxylic acids, is thermally concentrated into a thin precipitate containing 15% water. The product is then recovered in almost completely pure form by adding absolute ethanol at reflux temperature, cooling and filtration.
Primer 2 First 2
Alternativno pripremanje jedinjenja (VII) Alternative preparation of compound (VII)
A. Pripremanje 5-hidroksi-1,3-benzendikarboksilnog kiselog butil diestra A. Preparation of 5-hydroxy-1,3-benzenedicarboxylic acid butyl diester
920 g n-butanola i 583 g 5-hidroksi-1,3-benzendikarboksilne kiseline se napuni u esterifikacioni reaktor pod azotom. Doda se 32 g p-toluensulfoničnog kiselog monohidrata uz mešanje. Nastala suspenzija se zagreje do refluksa rastvarača, pritisak se postupno smanjuje do 350 mbar da se zadrži temperatura reakcione mešavine od 93 do 97oC. Ti uslovi se održavaju 7 sati uklanjajući formiranu vodu putem azeotropne destilacije. Nakon kompletiranja reakcije rastvor se ohladi do 50oC. 920 g of n-butanol and 583 g of 5-hydroxy-1,3-benzenedicarboxylic acid were charged to an esterification reactor under nitrogen. 32 g of p-toluenesulfonic acid monohydrate is added with stirring. The resulting suspension is heated to solvent reflux, the pressure is gradually reduced to 350 mbar to maintain the temperature of the reaction mixture at 93 to 97oC. These conditions are maintained for 7 hours by removing the formed water through azeotropic distillation. After the completion of the reaction, the solution is cooled to 50oC.
B. Pripremanje N,N'-bis-(2,3-dihidroksipropil)-5-hidroksi-1,3-benzendikarboksiamida B. Preparation of N,N'-bis-(2,3-dihydroxypropyl)-5-hydroxy-1,3-benzenedicarboxamide
Rastvor jedinjenja pripremljenog u koraku A) se dodaje sa 1305 g izoserinola, pritisak se spušta na 240 mbara, zagreje se do 95oC. Reakcija se produžava za 12 časova, uz postupno spuštanje pritiska na 30 mbara. The solution of the compound prepared in step A) is added with 1305 g of isoserinol, the pressure is reduced to 240 mbar, it is heated to 95oC. The reaction is prolonged for 12 hours, with a gradual lowering of the pressure to 30 mbar.
Nakon kompletiranja reakcije konačni rastvor se razblaži sa oko 2800 g vode i prečisti kroz dve kolone vezane u seriji sadržeći respektivno jako kiselu jonoizmenjivačku smolu da se ukloni višak izoserinola i slabu baznu jonoizmenjivačku smolu da se uklone anjonske nečistoće. Produkt se razblaži sa vodom. After the completion of the reaction, the final solution is diluted with about 2800 g of water and purified through two columns connected in series containing, respectively, a strongly acidic ion exchange resin to remove excess isoserinol and a weak base ion exchange resin to remove anionic impurities. The product is diluted with water.
Rastvor iz kolone se koncentriše do standardne zapremine. Doda se natrijum hidroksid da se dobije rastvor odgovarajuće natrijumove soli. The column solution is concentrated to standard volume. Sodium hydroxide is added to obtain a solution of the corresponding sodium salt.
Prema tome dobija se 4200 g 25% rastvora koji sadrži 1051 g željenog jedinjenja. Accordingly, 4200 g of a 25% solution containing 1051 g of the desired compound is obtained.
Izoserinol se ponovo dobija iz katjonske smole kako je to opisano u primeru 1. Isoserinol is recovered from the cationic resin as described in Example 1.
C. Pripremanje 2-hloro-N-metil-acetamida C. Preparation of 2-chloro-N-methyl-acetamide
Kondenzacija izme|u 784 g (6.4 mola) etil hloracetata i 549 g (7.1 mola) monometilamina (40% vodeni rastvor) se obavlja u reaktoru koji se drži na –5oC. Nakon kompletiranja dodavanja amina pomenuta temperatura održava se daljih 30 minuta. Condensation between 784 g (6.4 moles) of ethyl chloroacetate and 549 g (7.1 moles) of monomethylamine (40% aqueous solution) is carried out in a reactor kept at -5oC. After completing the addition of amine, the mentioned temperature is maintained for another 30 minutes.
Mešavina je razblažena sa 957 g vode i pH je podešen do kiselih vrednosti (3.5 <pH< 5). Rastvor se zatim termalno koncentriše pod redukovanim pritiskom do taloga od oko 1100 g. Težina se nadokna|uje dodavanjem 1570 g demineralizovane vode da se dobije 1970 g 30% vodenog rastvora koji sadrži 674 g 2-hloro-N-metilacetamida. The mixture was diluted with 957 g of water and the pH was adjusted to acidic values (3.5 <pH< 5). The solution is then thermally concentrated under reduced pressure to a precipitate of about 1100 g. The weight is compensated by adding 1570 g of demineralized water to give 1970 g of a 30% aqueous solution containing 674 g of 2-chloro-N-methylacetamide.
D. Pripremanje N,N’-bis(2,3-dihidroksipropil)-2,4,6-trijodo-5-[2-(metilanino)-2-oksoetoksi]-1,3-benzendikarboksamida. D. Preparation of N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[2-(methylanino)-2-oxoethoxy]-1,3-benzenedicarboxamide.
4200 g rastvora N,N’-bis-(2,3-dihidroksipropil)-5-hidroksi-1,3-benzendikarboksamida dobijenog u koraku B) se istovremeno doda sa ICl (uz održavanje temperature ispod 25oC) i 30% natrijum hidroksida da se održi pH 7. Dodavanje ICl završava se kada se redoks potencijal stabilizuje na 500 mV. Ukupno se napuni 5320 g ICl i 2580 g natrijum hidroksida. Nakon toga, unese se 10 g natrijum bisulfita da se uništi višak joda i da se potencijal smanji do –20 mV. 4200 g of the solution of N,N'-bis-(2,3-dihydroxypropyl)-5-hydroxy-1,3-benzenedicarboxamide obtained in step B) is added simultaneously with ICl (keeping the temperature below 25oC) and 30% sodium hydroxide to pH 7 is maintained. Addition of ICl ends when the redox potential stabilizes at 500 mV. A total of 5320 g of ICl and 2580 g of sodium hydroxide are charged. After that, 10 g of sodium bisulfite is introduced to destroy the excess iodine and to reduce the potential to -20 mV.
Nastali rastvor se zatim doda sa 1970 g rastvora 2-hrloro-N-metilacetamida dobijenog u koraku C). Mešavina se zagreva na 95oC tokom 7 časova i pH se održava na 5.8 dodavanjem 30% natrijum hidroksida. Nakon hla|ena na 30-40oC suspenzija se filtrirana i čvrsti deo se ispra sa vodom. The resulting solution is then added with 1970 g of the 2-chloro-N-methylacetamide solution obtained in step C). The mixture is heated to 95°C for 7 hours and the pH is maintained at 5.8 by adding 30% sodium hydroxide. After cooling to 30-40oC, the suspension is filtered and the solid part is washed with water.
Prema tome, dobija se 3350 g vlažnog produkta koji sadrži 2025 g željenog produkta. Therefore, 3350 g of wet product containing 2025 g of the desired product is obtained.
Prinos od 5-hidroksi-1,3-benzendikarboksilne kiseline: 81.2% Yield of 5-hydroxy-1,3-benzenedicarboxylic acid: 81.2%
E. Pripremanje jedinjenja (I) E. Preparation of compound (I)
2000 g jedinjenja pripremljenog u koraku D) se suspenduje u 8660 L dejonizovane vode i refluksuje. Suspenzija se doda sa 7 g 30% w/w natrijum hidroksida, zatim zagreva do 100oC uz održavanje te temperature tokom 2 časa. Mešavina se ohladi do 50oC uz dodavanje 172 g 30% w/w natrijum hidroksida, i postupno do 40oC tokom 2 časa. Nakon dodatna 4 časa na 40oC mešavina se ohladi do 20oC. 2000 g of the compound prepared in step D) is suspended in 8660 L of deionized water and refluxed. The suspension is added with 7 g of 30% w/w sodium hydroxide, then heated to 100oC while maintaining this temperature for 2 hours. The mixture was cooled to 50°C with the addition of 172 g of 30% w/w sodium hydroxide, and gradually to 40°C over 2 hours. After an additional 4 hours at 40oC, the mixture cools down to 20oC.
Nakon kompletiranja reakcije rastvor se reciklira na kolonu koja sadrži 1.13 L slabo kisele katjonske smole da se ukloni natrijum hidroksid prisutan na kraju reakcije, sve do pH 5.5. Rastvor se zatim unosi u 3.55 L R&H Amberlite 1600 apsopcione smole povezane u seriji na bateriju od četiri kolone koje sadrže jonoizmenjivačke smole opisane u WO 98/56504. Zapremine smola u četiri kolone su 2 L, 0.7 L, 0.47 L i 0.47 L respektivno. After completion of the reaction, the solution is recycled to a column containing 1.13 L of weakly acidic cation resin to remove the sodium hydroxide present at the end of the reaction, until pH 5.5. The solution is then introduced into 3.55 L of R&H Amberlite 1600 absorption resin connected in series to a battery of four columns containing the ion exchange resins described in WO 98/56504. The volumes of resins in the four columns are 2 L, 0.7 L, 0.47 L and 0.47 L respectively.
Rastvaranje produkta iz smola je praćeno spektrofotometrijski. The dissolution of the product from the resins was monitored spectrophotometrically.
^im apsorpcija počne da raste rastvor se sakuplja u reaktoru zajedno sa uzastopnim vodenim ispiranjima cele baterije kolona. As soon as the absorbance starts to increase, the solution is collected in the reactor together with successive water washes of the entire battery of columns.
Prečišćeni, desalinizovani rastvor je termalno koncentrisan pod redukovanim pritiskom do tankog taloga koji sadrži 0.22 dela vode po delu produkta (w/w). Talog je zatim dodan, pod refluksom, u 5 delova (w/w) apsolutnog etanola da bi se ponovo dobio produkt. The purified, desalinated solution was thermally concentrated under reduced pressure to a thin precipitate containing 0.22 parts water per part product (w/w). The precipitate was then added, under reflux, to 5 parts (w/w) of absolute ethanol to recover the product.
Claims (11)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998MI002574A IT1303797B1 (en) | 1998-11-27 | 1998-11-27 | PROCESS FOR THE PREPARATION OF N, N'-BIS (2,3-DIHYDROXYPROPYL) -5 - ((HYDROXIACETYL) METHYLAMINE) -2,4,6-TRIIODE-1,3-BENZENDICARBOXAMIDE. |
| PCT/EP1999/009118 WO2000032561A1 (en) | 1998-11-27 | 1999-11-25 | A process for the preparation of n,n'-bis[2, 3-dihydroxypropyl] -5-[ (hydroxyacetyl) methylamino]-2, 4,6-triiodo-1, 3-benzenedi carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME00606B true ME00606B (en) | 2011-12-20 |
Family
ID=11381150
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2009-88A ME00606B (en) | 1998-11-27 | 1999-11-25 | A process for the preparation of n,n'-bis[2, 3-dihydroxypropyl] -5-[ (hydroxyacetyl) methylamino]-2, 4,6-triiodo-1, 3-benzenedi carboxamide |
| MEP-88/09A MEP8809A (en) | 1998-11-27 | 1999-11-25 | A process for the preparation of n,n'-bis[2, 3-dihydroxypropyl] -5-[ (hydroxyacetyl) methylamino]-2, 4,6-triiodo-1, 3-benzenedi carboxamide |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-88/09A MEP8809A (en) | 1998-11-27 | 1999-11-25 | A process for the preparation of n,n'-bis[2, 3-dihydroxypropyl] -5-[ (hydroxyacetyl) methylamino]-2, 4,6-triiodo-1, 3-benzenedi carboxamide |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6420603B1 (en) |
| EP (1) | EP1133466B1 (en) |
| JP (1) | JP4439123B2 (en) |
| KR (1) | KR100630400B1 (en) |
| CN (1) | CN1163474C (en) |
| AT (1) | ATE247630T1 (en) |
| AU (1) | AU753601B2 (en) |
| BR (1) | BR9915608B1 (en) |
| CA (1) | CA2351717C (en) |
| CZ (1) | CZ296096B6 (en) |
| DE (1) | DE69910609T2 (en) |
| EA (1) | EA003253B1 (en) |
| ES (1) | ES2205949T3 (en) |
| HK (1) | HK1040988B (en) |
| HR (1) | HRP20010393B1 (en) |
| HU (1) | HU229092B1 (en) |
| IL (1) | IL143150A0 (en) |
| IT (1) | IT1303797B1 (en) |
| ME (2) | ME00606B (en) |
| NO (1) | NO327037B1 (en) |
| RS (1) | RS50038B (en) |
| SK (1) | SK285050B6 (en) |
| TR (1) | TR200101439T2 (en) |
| WO (1) | WO2000032561A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2093206A1 (en) * | 2008-02-20 | 2009-08-26 | BRACCO IMAGING S.p.A. | Process for the iodination of aromatic compounds |
| EP2243767A1 (en) | 2009-04-21 | 2010-10-27 | Bracco Imaging S.p.A | Process for the iodination of aromatic compounds |
| PT2451994E (en) | 2009-07-07 | 2014-01-07 | Bracco Imaging Spa | Process for the preparation of a iodinating agent |
| EP2277846A1 (en) * | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Obtaining free iodine in preparation of aqueous iodine chloride by adding potassium iodide |
| EP2394984A1 (en) | 2010-06-10 | 2011-12-14 | Bracco Imaging S.p.A | Process for the iodination of phenolic derivatives |
| IT1403988B1 (en) * | 2010-07-15 | 2013-11-08 | Bracco Imaging Spa | PROCESS FOR THE PREPARATION OF CONTRAST AGENTS. |
| WO2012136813A2 (en) | 2011-04-07 | 2012-10-11 | Universitetet I Oslo | Agents for medical radar diagnosis |
| KR101833334B1 (en) * | 2016-04-29 | 2018-02-28 | (주)유케이케미팜 | Novel intermediate compound and preparation process of iomeprol using thereof |
| KR102128423B1 (en) | 2018-09-17 | 2020-07-01 | (주)유케이케미팜 | Process for the proparation of contrast medium iomeprol |
| WO2023046815A1 (en) | 2021-09-24 | 2023-03-30 | Bracco Imaging Spa | Electrochemical iodination of n,n'-(2,3-dihydroxypropyl)-5-hydroxy-1,3-benzenedicarboxamide |
| KR20250006017A (en) | 2022-04-29 | 2025-01-10 | 브라코 이미징 에스.피.에이. | Method for producing 2,4,6-triiodophenol derivatives |
| WO2026017631A1 (en) | 2024-07-17 | 2026-01-22 | Bracco Imaging Spa | Process for the purification of 3-amino-1,2-propanediol (isoserinol) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1196363B (en) * | 1984-12-10 | 1988-11-16 | Bracco Ind Chimica Spa | DERIVATIVES OF 5-ALCOXY-2,4,6-TRIIODE- OR -TRIBROME-ISOPHTHALIC ACID, METHOD FOR THEIR PREPARATION AND RELATED RADIOLOGICAL CONTRAST MEANS |
| JP2585087B2 (en) * | 1987-05-22 | 1997-02-26 | ブラッコ インターナショナル ベ ヴェ | Method for producing 5-acylamino-2,4,6-triiodo- or -tribromo-benzoic acid derivative and novel 5-acylamino-2,4,6-triiodo or -tribromo-benzoic acid obtained by the method Derivative |
-
1998
- 1998-11-27 IT IT1998MI002574A patent/IT1303797B1/en active
-
1999
- 1999-11-25 AT AT99973018T patent/ATE247630T1/en active
- 1999-11-25 JP JP2000585203A patent/JP4439123B2/en not_active Expired - Lifetime
- 1999-11-25 CA CA2351717A patent/CA2351717C/en not_active Expired - Lifetime
- 1999-11-25 HR HR20010393A patent/HRP20010393B1/en not_active IP Right Cessation
- 1999-11-25 ME MEP-2009-88A patent/ME00606B/en unknown
- 1999-11-25 EP EP99973018A patent/EP1133466B1/en not_active Expired - Lifetime
- 1999-11-25 SK SK705-2001A patent/SK285050B6/en not_active IP Right Cessation
- 1999-11-25 DE DE69910609T patent/DE69910609T2/en not_active Expired - Lifetime
- 1999-11-25 WO PCT/EP1999/009118 patent/WO2000032561A1/en not_active Ceased
- 1999-11-25 BR BRPI9915608-3A patent/BR9915608B1/en not_active IP Right Cessation
- 1999-11-25 HU HU0104507A patent/HU229092B1/en unknown
- 1999-11-25 HK HK02102762.0A patent/HK1040988B/en not_active IP Right Cessation
- 1999-11-25 AU AU13862/00A patent/AU753601B2/en not_active Expired
- 1999-11-25 KR KR1020017006458A patent/KR100630400B1/en not_active Expired - Lifetime
- 1999-11-25 EA EA200100462A patent/EA003253B1/en not_active IP Right Cessation
- 1999-11-25 RS YUP-371/01A patent/RS50038B/en unknown
- 1999-11-25 ES ES99973018T patent/ES2205949T3/en not_active Expired - Lifetime
- 1999-11-25 CZ CZ20011833A patent/CZ296096B6/en not_active IP Right Cessation
- 1999-11-25 US US09/856,554 patent/US6420603B1/en not_active Expired - Lifetime
- 1999-11-25 ME MEP-88/09A patent/MEP8809A/en unknown
- 1999-11-25 IL IL14315099A patent/IL143150A0/en not_active IP Right Cessation
- 1999-11-25 CN CNB998136514A patent/CN1163474C/en not_active Expired - Lifetime
- 1999-11-25 TR TR2001/01439T patent/TR200101439T2/en unknown
-
2001
- 2001-05-23 NO NO20012547A patent/NO327037B1/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2356942C (en) | Preparation of iodixanol | |
| ME00606B (en) | A process for the preparation of n,n'-bis[2, 3-dihydroxypropyl] -5-[ (hydroxyacetyl) methylamino]-2, 4,6-triiodo-1, 3-benzenedi carboxamide | |
| EP1960349A1 (en) | Purification of iodixanol | |
| SK8997A3 (en) | Process for the preparation of 5-amino-2,4,6-triiodine-1,3- -benzenedicarboxylic acid | |
| CN105315184B (en) | A kind of fertile Preparation Method And Their Intermediate for Xi Ting | |
| IL128715A (en) | Process for iohexol manufacture | |
| EP1966110A1 (en) | Purification process of iodixanol | |
| MXPA01005126A (en) | A process for the preparation of n,n'-bis[2, 3-dihydroxypropyl]-5-[ (hydroxyacetyl) methylamino]-2, 4,6-triiodo-1, 3-benzenedi carboxamide | |
| JP2007169238A (en) | Method for purifying 6,6 '-(ethylenedioxy) di-2-naphthoic acid | |
| JP5668333B2 (en) | Method for producing high purity o-tolidine sulfone | |
| JP3316917B2 (en) | New phenylalanine salt crystals and their production | |
| JP2000191646A (en) | Production of anthrapyridone-based compound | |
| JPH03190847A (en) | Purification of 3,4-dichloronitrobenzene | |
| JP2002179650A (en) | Method for producing isatin bis (o-cresol) | |
| WO1996035662A1 (en) | Process for producing alkylenediaminediorganic acid and salts thereof | |
| JPS63225352A (en) | Production of 2,7-naphthalenedisulfonic acid | |
| JPH0421666A (en) | Method for purifying metal aminoethylsulfonate | |
| PL64643B1 (en) | ||
| HK1001393A1 (en) | Process for the manufacturing of iodinated contrast agents | |
| HK1001393B (en) | Process for the manufacturing of iodinated contrast agents | |
| JPH0530818B2 (en) |